AngioDynamics ANGO International — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's international — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's international — net sales?
- AngioDynamics (ANGO) reported international — net sales of $11.15M in Q4 2025.
- How has AngioDynamics's international — net sales changed year-over-year?
- AngioDynamics's international — net sales increased by 4.5% year-over-year, from $10.66M to $11.15M.
- What is the long-term trend for AngioDynamics's international — net sales?
- Over 4 years (2021 to 2025), AngioDynamics's international — net sales has grown at a -6.3% compound annual growth rate (CAGR), from $53.97M to $41.52M.
- What does international — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and therapeutic solutions within international markets, excluding the domestic home market. It serves as a key indicator of the company's global footprint and its ability to successfully commercialize its peripheral vascular and oncology product portfolios outside of its primary region. Monitoring this figure helps investors assess the company's international market penetration and growth strategy.